Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
ChengDu Sheng Nuo Biotec
688117
4
Shenzhen Jasic Technology
300193
5
Zhejiang Huaye Plastics Machinery
301616
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.53%23.68B | 23.99%5.97B | 7.32%6.44B | 8.97%5.82B | 3.49%5.46B | -4.82%21.43B | -7.57%4.81B | -6.38%6B | -4.52%5.34B | -0.53%5.27B |
Operating revenue | 10.53%23.68B | 23.99%5.97B | 7.32%6.44B | 8.97%5.82B | 3.49%5.46B | -4.82%21.43B | -7.57%4.81B | -6.38%6B | -4.52%5.34B | -0.53%5.27B |
Cost of revenue | 3.68%11.66B | 12.42%3B | 3.06%3.14B | 9.07%2.86B | -8.55%2.66B | -5.25%11.24B | -15.93%2.67B | -6.68%3.04B | -5.61%2.63B | 9.68%2.91B |
Gross profit | 18.09%12.03B | 38.35%2.97B | 11.71%3.3B | 8.87%2.96B | 18.32%2.8B | -4.33%10.18B | 5.45%2.15B | -6.07%2.96B | -3.45%2.72B | -10.76%2.36B |
Operating expense | 8.38%10.73B | 17.71%2.96B | 6.29%2.71B | 2.71%2.61B | 6.82%2.46B | -0.11%9.9B | -6.89%2.51B | -1.43%2.55B | 4.95%2.54B | 4.11%2.3B |
Selling and administrative expenses | 10.10%10.92B | 9.64%8.83B | 12.42%724M | 14.59%707M | 9.32%657M | -1.01%9.91B | 0.40%8.05B | -6.80%644M | -6.94%617M | -6.24%601M |
-Selling and marketing expense | 8.69%8.78B | 7.68%6.69B | 12.42%724M | 14.59%707M | 9.32%657M | -3.46%8.08B | -2.45%6.21B | -6.80%644M | -6.94%617M | -6.24%601M |
-General and administrative expense | 16.26%2.14B | ---- | ---- | ---- | ---- | 11.39%1.84B | ---- | ---- | ---- | ---- |
Other operating expenses | -161.54%-80M | -7.58%-5.95B | 9.76%2.11B | -1.78%1.93B | 3.17%1.82B | -25.71%130M | -4.98%-5.53B | -2.97%1.93B | 6.91%1.97B | 9.21%1.77B |
Operating profit | 362.72%1.29B | 103.00%11M | 45.37%596M | 98.29%347M | 460.00%336M | -61.73%279M | 44.73%-367M | -27.30%410M | -55.36%175M | -86.24%60M |
Net non-operating interest income expense | -46.99%-122M | -90.24%8M | 104.76%4M | 19.23%-42M | -225.00%-91M | 27.83%-83M | -47.10%82M | 45.45%-84M | 42.86%-52M | -7.69%-28M |
Non-operating interest income | 46.15%57M | 36.36%-14M | -6.45%29M | 5.26%20M | 84.62%24M | 69.57%39M | -144.44%-22M | 287.50%31M | 18.75%19M | 62.50%13M |
Non-operating interest expense | 38.13%221M | 130.30%20M | -78.26%25M | -12.68%62M | 180.49%115M | 16.79%160M | 60.00%-66M | -29.01%115M | -33.64%71M | 20.59%41M |
Total other finance cost | -10.53%-42M | ---- | ---- | ---- | ---- | -3,900.00%-38M | ---- | ---- | ---- | ---- |
Other net income (expense) | ||||||||||
Special income (charges) | 475.00%45M | ---- | ---- | ---- | ---- | 80.00%-12M | ---- | ---- | ---- | ---- |
-Less:Other special charges | -328.57%-30M | ---- | ---- | ---- | ---- | -133.33%-7M | ---- | ---- | ---- | ---- |
-Write off | -178.95%-15M | ---- | ---- | ---- | ---- | -69.84%19M | ---- | ---- | ---- | ---- |
Income before tax | 1,624.62%1.12B | 93.01%-29M | 84.36%601M | 147.15%304M | 665.63%245M | -83.25%65M | 43.46%-415M | -20.68%326M | -59.00%123M | -92.21%32M |
Income tax | 139.52%297M | 85.71%-2M | 141.82%133M | 244.44%93M | 34.55%74M | -7.46%124M | 94.44%-14M | -84.06%55M | 145.00%27M | -45.54%55M |
Net income | 6,042.86%832M | 94.71%-19M | 70.00%476M | 116.84%206M | 666.67%170M | -102.19%-14M | 30.02%-359M | -20.45%280M | -69.26%95M | -106.12%-30M |
Net income continuous Operations | 1,520.69%824M | 93.27%-27M | 73.70%469M | 119.79%211M | 812.50%171M | -122.83%-58M | 16.80%-401M | 309.09%270M | -73.33%96M | -107.74%-24M |
Net income discontinuous operations | -81.82%8M | -83.33%7M | -30.00%7M | -500.00%-6M | 83.33%-1M | -88.54%44M | 235.48%42M | -96.50%10M | 98.08%-1M | -103.33%-6M |
Minority interest income | 11.48%68M | 0.00%20M | 57.14%33M | 45.45%16M | 0 | 134.62%61M | 2,100.00%20M | 320.00%21M | -26.67%11M | 12.50%9M |
Net income attributable to the parent company | 1,118.67%764M | 89.71%-39M | 71.04%443M | 126.19%190M | 535.90%170M | -112.25%-75M | 25.98%-379M | -25.36%259M | -71.43%84M | -108.09%-39M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 1,118.67%764M | 89.71%-39M | 71.04%443M | 126.19%190M | 535.90%170M | -112.25%-75M | 25.98%-379M | -25.36%259M | -71.43%84M | -108.09%-39M |
Basic earnings per share | 1,119.05%2.14 | 89.62%-0.11 | 71.03%1.24 | 125.53%0.53 | 531.82%0.475 | -112.57%-0.21 | 22.63%-1.06 | -24.08%0.725 | -70.63%0.235 | -108.63%-0.11 |
Diluted earnings per share | 1,119.05%2.14 | 89.62%-0.11 | 71.03%1.24 | 125.53%0.53 | 531.82%0.475 | -112.57%-0.21 | 22.63%-1.06 | -24.08%0.725 | -70.63%0.235 | -108.63%-0.11 |
Dividend per share | -1.47%0.3501 | 0 | 0 | -1.47%0.3501 | 0 | -77.98%0.3554 | 0 | 0 | -77.98%0.3554 | 0 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |